TocilizumabV1, Main, Merge, indexHead, AutAff.i

Author's uniq id: Peters M
Total number of names:
Total number of records with affiliations: 56

M Peters

NONE (BIBLIO)

M. A. Peters

Allemagne Institute of Experimental Musculoskeletal Medicine, Muenster Muenster Muenster	002C08
	002E26
Grenzach-Whylen	002E26
Grenzach-Whylen	002E26

M. B. Peters

NONE (BIBLIO)

001475

M. C. Peters

NONE (BIBLIO)

000446

M. M. Peters

NONE (BIBLIO)

000114

M. Peters

NONE (BIBLIO)

000309
001005
001B40

M.A. Peters

NONE (BIBLIO)

000787

M.J. Peters

NONE (BIBLIO)

000109
000458
000B74
001177

M.J.L. Peters

NONE (BIBLIO)

000458
000C88
001177

M.L. Peters

NONE (BIBLIO)

000372

MA Peters

NONE (BIBLIO)

002777

MC Peters

NONE (BIBLIO)

000848
001033

MJ Peters

NONE (BIBLIO)

000344
000547
000804
000982
000983
000B30
000B94
000D60
000F53
001458
001716
001878
001C19
001C41
002477
002494
002787
002793
003A01

MJL Peters

NONE (BIBLIO)

000B10
000B12
000E49
000F04
000F44
001C41

ML Peters

NONE (BIBLIO)

000668

MS Peters

NONE (BIBLIO)

000C19

Marvin A. Peters

Medical Affairs, Roche Pharma AG, Grenzach, Germany. Allemagne Medical Affairs, Roche Pharma AG, Grenzach Grenzach Grenzach Grenzach	004520
Roche Pharma AG, Grenzach-Wyhlen, Germany and. Germany and	001A78
Germany and	001A78

<g><k>Peters M</k>
<l><g><k>M Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000376</i>
<i>000773</i>
<i>000909</i>
<i>000E24</i>
</l>
<n>4</n>
<t>4</t>
</g>
</l>
<n>1</n>
<t>4</t>
</g>
<g><k>M. A. Peters</k>
<l><g><k><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Experimental Musculoskeletal Medicine, Muenster</wicri:regionArea>
<wicri:noRegion>Muenster</wicri:noRegion>
<wicri:noRegion>Muenster</wicri:noRegion>
</affiliation>
</k>
<l><i>002C08</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation></affiliation>
</k>
<l><i>002E26</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation><wicri:noCountry code="subField">Grenzach-Whylen</wicri:noCountry>
</affiliation>
</k>
<l><i>002E26</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><wicri:noCountry code="subField">Grenzach-Whylen</wicri:noCountry>
</k>
<l><i>002E26</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>4</n>
<t>4</t>
</g>
<g><k>M. B. Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>001475</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>M. C. Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000446</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>M. M. Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000114</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>M. Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000309</i>
<i>001005</i>
<i>001B40</i>
</l>
<n>3</n>
<t>3</t>
</g>
</l>
<n>1</n>
<t>3</t>
</g>
<g><k>M.A. Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000787</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>M.J. Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000109</i>
<i>000458</i>
<i>000B74</i>
<i>001177</i>
</l>
<n>4</n>
<t>4</t>
</g>
</l>
<n>1</n>
<t>4</t>
</g>
<g><k>M.J.L. Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000458</i>
<i>000C88</i>
<i>001177</i>
</l>
<n>3</n>
<t>3</t>
</g>
</l>
<n>1</n>
<t>3</t>
</g>
<g><k>M.L. Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000372</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>MA Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>002777</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>MC Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000848</i>
<i>001033</i>
</l>
<n>2</n>
<t>2</t>
</g>
</l>
<n>1</n>
<t>2</t>
</g>
<g><k>MJ Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000344</i>
<i>000547</i>
<i>000804</i>
<i>000982</i>
<i>000983</i>
<i>000B30</i>
<i>000B94</i>
<i>000D60</i>
<i>000F53</i>
<i>001458</i>
<i>001716</i>
<i>001878</i>
<i>001C19</i>
<i>001C41</i>
<i>002477</i>
<i>002494</i>
<i>002787</i>
<i>002793</i>
<i>003A01</i>
</l>
<n>19</n>
<t>19</t>
</g>
</l>
<n>1</n>
<t>19</t>
</g>
<g><k>MJL Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000B10</i>
<i>000B12</i>
<i>000E49</i>
<i>000F04</i>
<i>000F44</i>
<i>001C41</i>
</l>
<n>6</n>
<t>6</t>
</g>
</l>
<n>1</n>
<t>6</t>
</g>
<g><k>ML Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000668</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>MS Peters</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000C19</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k>Marvin A. Peters</k>
<l><g><k><affiliation wicri:level="1"><nlm:affiliation>Medical Affairs, Roche Pharma AG, Grenzach, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Medical Affairs, Roche Pharma AG, Grenzach</wicri:regionArea>
<wicri:noRegion>Grenzach</wicri:noRegion>
<wicri:noRegion>Grenzach</wicri:noRegion>
<wicri:noRegion>Grenzach</wicri:noRegion>
</affiliation>
</k>
<l><i>004520</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation><nlm:affiliation>Roche Pharma AG, Grenzach-Wyhlen, Germany and.</nlm:affiliation>
<wicri:noCountry code="subField">Germany and</wicri:noCountry>
</affiliation>
</k>
<l><i>001A78</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><wicri:noCountry code="subField">Germany and</wicri:noCountry>
</k>
<l><i>001A78</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>3</n>
<t>3</t>
</g>
</l>
<n>17</n>
<t>56</t>
</g>

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021

	Serveur d'exploration Tocilizumab
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Tocilizumab